Unlock with Our Memory Endpoint Solutions
Cerebral Innovations provides a cutting-edge memory endpoint designed specifically for clinical trials. Our unique approach captures both learning rates and consolidated memory, cognitive domains often overlooked in traditional assessments. By leveraging an agentic AI administrator, we offer a more comprehensive evaluation of cognitive function.
Clinical trials supported with our advanced memory assessment tools.
0
+
Data accuracy improvement with our AI-driven memory endpoint.
0
%
Movement Disorders with NeuroQuantix
NeuroQuantix offers unparalleled precision in quantifying movement disorders, providing sensitive, publication-backed metrics. This enables reliable drug efficacy measurement in clinical trials, ensuring accurate and regulatory-compliant endpoint solutions for biotech and pharmaceutical firms. Our technology supports over 50 trials across various neurological indications.
Tremor Quantification
NeuroQuantix precisely measures tremor severity, frequency, and amplitude, providing objective data for clinical trials. This ensures accurate assessment of therapeutic interventions and regulatory compliance.
Dystonia Analysis
Our software offers detailed analysis of dystonic movements, quantifying the severity and impact on motor function. This supports reliable drug efficacy measurement and regulatory submissions.
Bradykinesia Detection
NeuroQuantix accurately detects and quantifies bradykinesia, providing sensitive metrics for assessing motor function in clinical trials. This ensures precise evaluation of therapeutic effects.